Farrand E - Search Results

1

Clinical Trials for Idiopathic Pulmonary Fibrosis and the Role of Health Systems.

Farrand E, Limper AH. Farrand E, et al. Clin Chest Med. 2021 Jun;42(2):287-294. doi: 10.1016/j.ccm.2021.03.006. Clin Chest Med. 2021. PMID: 34024404 Review.

2

Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis.

Lombardi F, Stewart I, Fabbri L, Adams W, Kawano-Dourado L, Ryerson CJ, Jenkins G; REMAP-ILD Consortium. Lombardi F, et al. BMJ Open Respir Res. 2024 Feb 27;11(1):e002163. doi: 10.1136/bmjresp-2023-002163. BMJ Open Respir Res. 2024. PMID: 38413120 Free PMC article.

3

Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients.

Farrand E, Iribarren C, Vittinghoff E, Levine-Hall T, Ley B, Minowada G, Collard HR. Farrand E, et al. Chest. 2021 Jan;159(1):219-227. doi: 10.1016/j.chest.2020.07.035. Epub 2020 Jul 24. Chest. 2021. PMID: 32717266 Free PMC article.

4

Differences in Health Care and Palliative Care Use at the End of Life: A Comparison Study Among Lung Cancer, COPD, and Idiopathic Pulmonary Fibrosis.

Suen AO, Bischoff K, Iyer AS, Radhakrishnan K, Fenton C, Singer JP, Sudore RL, Kotwal A, Farrand E. Suen AO, et al. Among authors: farrand e. Chest. 2024 Dec;166(6):1487-1496. doi: 10.1016/j.chest.2024.08.018. Epub 2024 Aug 24. Chest. 2024. PMID: 39186972 Free PMC article.

5

Is corticosteroid use truly not associated with improved outcomes in AE-IPF? - Reply.

Farrand E, Collard HR. Farrand E, et al. Respirology. 2020 Jun;25(6):659-660. doi: 10.1111/resp.13825. Epub 2020 Apr 19. Respirology. 2020. PMID: 32307799 Free article. No abstract available.

6

Differences in Patient Outcomes across the Pulmonary Fibrosis Foundation Care Center Network.

Boente RD, White EN, Baxter CM, Shore JE, Collard HR, Lee JS; PFF Best Practices Committee. Boente RD, et al. Am J Respir Crit Care Med. 2023 Jan 15;207(2):214-218. doi: 10.1164/rccm.202206-1173LE. Am J Respir Crit Care Med. 2023. PMID: 36107160 No abstract available.

7

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.

Farrand E, Vittinghoff E, Ley B, Butte AJ, Collard HR. Farrand E, et al. Respirology. 2020 Jun;25(6):629-635. doi: 10.1111/resp.13753. Epub 2019 Dec 17. Respirology. 2020. PMID: 31846126

8

Digital outcome measures in pulmonary clinical trials.

Farrand E, Swigris JJ. Farrand E, et al. Curr Opin Pulm Med. 2023 Jul 1;29(4):322-327. doi: 10.1097/MCP.0000000000000972. Epub 2023 May 16. Curr Opin Pulm Med. 2023. PMID: 37191175 Review.

9

Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease.

Comes A, Wong AW, Fisher JH, Morisset J, Johannson KA, Farrand E, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Sadatsafavi M, Shapera S, To T, Wilcox PG, Collard HR, Ryerson CJ. Comes A, et al. Among authors: farrand e. Chest. 2022 May;161(5):1320-1329. doi: 10.1016/j.chest.2021.11.008. Epub 2021 Nov 14. Chest. 2022. PMID: 34788669

10

Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity Pneumonitis.

Mullin ML, Fernandez G, Marinescu DC, Zheng B, Wong AW, Assayag D, Fisher JH, Johannson KA, Khalil N, Kolb M, Manganas H, Marcoux V, Morisset J, Min B, Farrand E, Ryerson CJ. Mullin ML, et al. Among authors: farrand e. Chest. 2024 Jun;165(6):1435-1443. doi: 10.1016/j.chest.2023.12.019. Epub 2023 Dec 19. Chest. 2024. PMID: 38128609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters